Mercator Medical (MRC.WA) Stock Price

Mercator Medical Price

GPW·CLOSED
53.30PLN+0.30 (+0.56 %)
Market closed

Revenue has compounded at 13.8% per year over the past 14 years to 542.49 M PLN. Earnings per share have grown at 33.9% per year over the last 14 years. Mercator Medical's net margin stands at 9.4%, down from 50.7% several years earlier. Mercator Medical currently offers a dividend yield of about 4.69%. The dividend has grown at 63.5% per year over the past 9 years. The stock trades about 42% above its 52-week low.

Mercator Medical stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Mercator Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Mercator Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Mercator Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Mercator Medical Stock Price History
DateMercator Medical Price
8/7/202653.30 PLN
8/6/202653.00 PLN
8/5/202654.70 PLN
8/4/202653.00 PLN
7/31/202651.30 PLN
7/30/202651.30 PLN
7/29/202651.00 PLN
7/28/202650.40 PLN
7/27/202650.90 PLN
7/24/202650.10 PLN
7/23/202653.00 PLN
7/22/202651.00 PLN
7/21/202651.90 PLN
7/20/202652.00 PLN
7/17/202653.70 PLN
7/16/202653.40 PLN
7/15/202653.70 PLN
7/14/202653.60 PLN
7/13/202653.20 PLN
7/10/202652.70 PLN
7/9/202653.50 PLN
7/8/202651.30 PLN
7/7/202651.60 PLN
7/6/202650.50 PLN
7/3/202651.80 PLN
7/2/202650.40 PLN
7/1/202649.70 PLN
6/30/202648.80 PLN
6/29/202649.20 PLN
6/26/202649.50 PLN
6/25/202650.40 PLN
6/24/202650.40 PLN
6/23/202650.40 PLN
6/22/202650.30 PLN
6/19/202650.40 PLN
6/18/202650.90 PLN
6/17/202650.80 PLN
6/16/202650.50 PLN
6/15/202651.00 PLN
6/12/202653.00 PLN
6/11/202653.80 PLN
6/10/202653.50 PLN
6/9/202654.40 PLN
6/8/202656.70 PLN
6/5/202654.00 PLN
6/3/202654.80 PLN
6/2/202655.50 PLN
6/1/202655.00 PLN
5/29/202658.00 PLN
5/28/202656.60 PLN
5/27/202656.00 PLN
5/26/202659.50 PLN
5/25/202660.70 PLN
5/22/202662.00 PLN
5/21/202659.00 PLN
5/20/202658.20 PLN
5/19/202659.50 PLN
5/18/202660.00 PLN
5/15/202657.30 PLN
5/14/202658.20 PLN
5/13/202659.40 PLN
5/12/202658.20 PLN
5/11/202661.00 PLN
5/8/202659.50 PLN
5/7/202657.80 PLN
5/6/202651.50 PLN
5/5/202648.30 PLN
5/4/202647.65 PLN
4/30/202648.50 PLN
4/29/202649.40 PLN
4/28/202648.40 PLN
4/27/202649.05 PLN
4/24/202651.00 PLN
4/23/202652.10 PLN
4/22/202653.10 PLN
4/21/202652.00 PLN
4/20/202652.60 PLN
4/17/202651.30 PLN
4/16/202652.40 PLN
4/15/202652.00 PLN
4/14/202654.00 PLN
4/13/202652.70 PLN
4/10/202652.70 PLN
4/9/202655.30 PLN
4/8/202653.90 PLN
4/7/202661.10 PLN
4/2/202654.20 PLN
4/1/202649.90 PLN
3/31/202651.50 PLN
3/30/202645.95 PLN
3/27/202641.40 PLN
3/26/202643.20 PLN
3/25/202644.85 PLN
3/24/202644.40 PLN
3/23/202642.45 PLN
3/20/202641.90 PLN
3/19/202641.00 PLN
3/18/202639.95 PLN
3/17/202640.20 PLN
3/16/202639.45 PLN
3/13/202639.50 PLN
3/12/202639.60 PLN
3/11/202640.00 PLN
3/10/202639.10 PLN
3/9/202639.10 PLN
3/6/202639.25 PLN
3/5/202639.50 PLN
3/4/202640.10 PLN
3/3/202639.85 PLN
3/2/202640.70 PLN
2/27/202640.65 PLN
2/26/202640.95 PLN
2/25/202640.60 PLN
2/24/202640.15 PLN
2/23/202640.30 PLN
2/20/202640.25 PLN
2/19/202640.60 PLN
2/18/202640.60 PLN
2/17/202641.00 PLN
2/16/202640.55 PLN
2/13/202640.65 PLN
2/12/202640.95 PLN
2/11/202640.90 PLN
2/10/202640.95 PLN
2/9/202640.95 PLN
2/6/202640.80 PLN
2/5/202640.90 PLN
2/4/202641.00 PLN
2/3/202641.00 PLN
2/2/202640.85 PLN
1/30/202640.95 PLN
1/29/202641.15 PLN
1/28/202641.05 PLN
1/27/202641.00 PLN
1/26/202640.75 PLN
1/23/202640.45 PLN
1/22/202640.05 PLN
1/21/202640.75 PLN
1/20/202640.60 PLN
1/19/202641.10 PLN
1/16/202640.95 PLN
1/15/202640.70 PLN
1/14/202640.80 PLN
1/13/202640.80 PLN
1/12/202641.45 PLN
1/9/202641.45 PLN
1/8/202641.55 PLN
1/7/202641.75 PLN
1/5/202641.65 PLN
1/2/202639.60 PLN
12/30/202537.90 PLN
12/29/202537.75 PLN
12/23/202537.45 PLN
12/22/202538.00 PLN
12/19/202538.50 PLN
12/18/202538.25 PLN
12/17/202537.80 PLN
12/16/202538.10 PLN
12/15/202538.00 PLN
12/12/202538.30 PLN
12/11/202538.20 PLN
12/10/202538.00 PLN
12/9/202538.50 PLN
12/8/202538.60 PLN
12/5/202538.80 PLN
12/4/202538.85 PLN
12/3/202539.30 PLN
12/2/202539.80 PLN
12/1/202540.30 PLN
11/28/202538.80 PLN
11/27/202538.90 PLN
11/26/202539.00 PLN
11/25/202539.20 PLN
11/24/202539.40 PLN
11/21/202539.20 PLN
11/20/202539.35 PLN
11/19/202539.70 PLN
11/18/202539.65 PLN
11/17/202539.95 PLN
11/14/202539.60 PLN
11/13/202539.95 PLN
11/12/202540.10 PLN
11/10/202539.80 PLN
11/7/202539.85 PLN
11/6/202540.00 PLN
11/5/202540.00 PLN
11/4/202539.85 PLN
11/3/202540.45 PLN
10/31/202540.70 PLN
10/30/202540.50 PLN
10/29/202540.25 PLN
10/28/202540.70 PLN
10/27/202541.00 PLN
10/24/202541.15 PLN
10/23/202541.05 PLN
10/22/202540.90 PLN
10/21/202541.10 PLN
10/20/202541.30 PLN
10/17/202541.70 PLN
10/16/202541.85 PLN
10/15/202541.80 PLN
10/14/202541.45 PLN
10/13/202541.60 PLN
10/10/202542.20 PLN
10/9/202542.60 PLN
10/8/202543.50 PLN
10/7/202543.00 PLN
10/6/202543.05 PLN
10/3/202543.15 PLN
10/2/202543.55 PLN
10/1/202544.05 PLN
9/30/202544.10 PLN
9/29/202543.80 PLN
9/26/202543.70 PLN
9/25/202543.85 PLN
9/24/202543.95 PLN
9/23/202543.65 PLN
9/22/202544.40 PLN
9/19/202544.00 PLN
9/18/202542.90 PLN
9/17/202543.30 PLN
9/16/202543.50 PLN
9/15/202543.70 PLN
9/12/202543.80 PLN
9/11/202544.30 PLN
9/10/202543.90 PLN
9/9/202543.90 PLN
9/8/202543.80 PLN
9/5/202544.20 PLN
9/4/202544.00 PLN
9/3/202544.50 PLN
9/2/202544.20 PLN
9/1/202544.40 PLN
8/29/202544.20 PLN
8/28/202544.45 PLN
8/27/202544.45 PLN
8/26/202544.85 PLN
8/25/202544.65 PLN
8/22/202544.70 PLN
8/21/202544.80 PLN
8/20/202544.80 PLN
8/19/202545.60 PLN
8/18/202545.80 PLN
8/14/202545.60 PLN
8/13/202545.60 PLN
8/12/202547.50 PLN
Access this data via the Eulerpool API
Get Free API Key

Mercator Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
420.41 M PLN
14.36 M PLN
7.64 M PLN
Jan 1, 2019
540.33 M PLN
6.80 M PLN
-2.33 M PLN
Jan 1, 2020
1.83 B PLN
1.05 B PLN
930.19 M PLN
Jan 1, 2021
1.73 B PLN
503.37 M PLN
446.87 M PLN
Jan 1, 2022
542.51 M PLN
-190.13 M PLN
-189.62 M PLN
Jan 1, 2023
469.06 M PLN
-108.08 M PLN
-19.68 M PLN
Jan 1, 2024
542.49 M PLN
26.87 M PLN
51.05 M PLN
Jan 1, 2025 (e)
687.57 M PLN
-39.88 M PLN
31.76 M PLN

Mercator Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 11, 2026, 2:41 PM
 
REVENUEB PLN
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB PLN
EBITB PLN
EBIT MARGIN%
NET INCOMEM PLN
NET INCOME GROWTH%
DIV.PLN
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025e
0.090.120.130.150.170.230.260.300.420.541.831.730.540.470.540.69
–32.9512.8211.3614.2934.5216.3714.0740.0028.57239.63-5.83-68.62-13.4715.5726.75
5.686.849.0910.2010.7110.6210.656.007.625.3762.7636.024.802.3512.5512.55
0.010.010.010.020.020.020.030.020.030.031.150.620.030.010.070.09
––0.010.010.010.020.020.010.010.011.050.50-0.19-0.110.03-0.04
2.273.426.067.487.747.086.461.673.331.1157.1429.13-35.06-23.034.80-5.68
––7.006.0010.0010.0013.004.007.00-2.00930.00446.00-189.00-19.0051.0031.00
–––-14.2966.67–30.00-69.2375.00-128.57-46,600.00-52.04-142.38-89.95-368.42-39.22
––––0.030.25–0.13––0.50––2.50–1.61
–––––733.33––––––––––
2.202.206.506.508.648.7010.5910.5910.5910.5910.5310.659.778.279.399.39
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Mercator Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Mercator Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Mercator Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Mercator Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Mercator Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Mercator Medical stock margins

The Mercator Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mercator Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mercator Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
7.82 %
3.42 %
1.82 %
Jan 1, 2019
5.40 %
1.26 %
-0.43 %
Jan 1, 2020
62.78 %
57.17 %
50.71 %
Jan 1, 2021
36.02 %
29.14 %
25.87 %
Jan 1, 2022
4.86 %
-35.05 %
-34.95 %
Jan 1, 2023
2.41 %
-23.04 %
-4.19 %
Jan 1, 2024
12.69 %
4.95 %
9.41 %
Jan 1, 2025 (e)
12.69 %
-5.80 %
4.62 %

Mercator Medical Stock Revenue, EBIT, Earnings per Share

The Mercator Medical earnings per share therefore indicates how much revenue Mercator Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
39.70 PLN
1.36 PLN
0.72 PLN
Jan 1, 2019
51.03 PLN
0.64 PLN
-0.22 PLN
Jan 1, 2020
174.18 PLN
99.57 PLN
88.33 PLN
Jan 1, 2021
162.24 PLN
47.28 PLN
41.97 PLN
Jan 1, 2022
55.53 PLN
-19.46 PLN
-19.41 PLN
Jan 1, 2023
56.74 PLN
-13.07 PLN
-2.38 PLN
Jan 1, 2024
57.77 PLN
2.86 PLN
5.44 PLN
Jan 1, 2025 (e)
73.23 PLN
-4.25 PLN
3.38 PLN

Mercator Medical business model & stock analysis

Mercator Medical SA is a leading company in the production and distribution of medical disposable products and protective equipment.

Mercator Medical SWOT Analysis

Strengths

Mercator Medical SA has several strengths that contribute to its success:

  • Strong market position: Mercator Medical SA is a leading player in the global medical disposable products market.
  • Wide product portfolio: The company offers a diverse range of high-quality medical gloves and other personal protective equipment (PPE) products.
  • Quality assurance: Mercator Medical SA emphasizes strict quality control measures, ensuring its products meet international standards.
  • Established distribution network: The company has a well-established network of distributors and partners worldwide, enabling efficient product distribution.
  • Brand reputation: Mercator Medical SA is recognized as a trusted and reliable brand in the healthcare industry.

Weaknesses

Despite its strengths, Mercator Medical SA also has a few weaknesses that may hinder its growth:

  • Dependence on suppliers: The company relies on a limited number of suppliers for raw materials, which may lead to supply chain disruptions.
  • Cost structure: Mercator Medical SA's production costs are impacted by various factors such as raw material prices and currency fluctuations.
  • Brand awareness in certain markets: While the company has a strong presence in many regions, its brand may not be as recognized in some geographical markets.
  • Competition: The medical supplies industry is highly competitive, and Mercator Medical SA faces competition from both established companies and new entrants.

Opportunities

There are several opportunities that Mercator Medical SA can capitalize on:

  • Global market expansion: The demand for medical disposable products is increasing worldwide, presenting opportunities for Mercator Medical SA to enter new markets.
  • Product diversification: The company can explore expanding its product range beyond gloves to cater to a wider range of healthcare needs.
  • Growing healthcare industry: The increasing focus on healthcare infrastructure development and public health initiatives opens avenues for Mercator Medical SA to supply its products to hospitals, clinics, and healthcare facilities.
  • Technological advancements: Mercator Medical SA can leverage emerging technologies to enhance its manufacturing processes and improve product performance.

Threats

Mercator Medical SA should be aware of the following threats in its operating environment:

  • Pricing pressure: Intense competition may result in price wars, potentially impacting Mercator Medical SA's profit margins.
  • Regulatory challenges: Compliance with various regulations and standards in different countries adds complexity to the company's operations.
  • Supply chain disruptions: Any disruptions in the supply chain, such as transportation issues or raw material shortages, could affect the company's ability to fulfill orders timely.
  • Economic uncertainties: Volatile economic conditions and currency fluctuations can create financial instability and impact Mercator Medical SA's profitability.

Mercator Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Mercator Medical historical P/E ratio, EBIT multiple, and P/S ratio

Mercator Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Mercator Medical shares outstanding

The number of shares of Mercator Medical was 9.39 M in 2025. This indicates how many shares Mercator Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
10.59 M Stocks
Jan 1, 2019
10.59 M Stocks
Jan 1, 2020
10.53 M Stocks
Jan 1, 2021
10.65 M Stocks
Jan 1, 2022
9.77 M Stocks
Jan 1, 2023
8.27 M Stocks
Jan 1, 2024
9.39 M Stocks
Jan 1, 2025 (e)
9.39 M Stocks

Mercator Medical Dividend History

6 years of dividend payments

YearAnnual DividendYoY ChangePayments
20251.61PLN↓ 35.6%1×
Jul 25, 20251.61PLN↓ 35.6%1/1
20232.50PLN↑ 400.0%1×
20200.50PLN↑ 284.6%1×
20170.13PLN↓ 48.0%1×
20150.25PLN↑ 733.3%1×
20140.03PLN—1×

Mercator Medical dividend history and estimates

In 2025, Mercator Medical paid a dividend amounting to 1.61 PLN. Dividend means that Mercator Medical distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2014
0.03 PLN
0.00 PLN
Jan 1, 2015
0.25 PLN
0.00 PLN
Jan 1, 2017
0.13 PLN
0.00 PLN
Jan 1, 2020
0.50 PLN
0.00 PLN
Jan 1, 2023
2.50 PLN
0.00 PLN
Jan 1, 2025
1.61 PLN
0.00 PLN

Mercator Medical dividend payout ratio

In 2025, Mercator Medical had a payout ratio of 47.60%. The payout ratio indicates the percentage of the company's profits that Mercator Medical distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
15.02 %
Jan 1, 2019
14.51 %
Jan 1, 2020
0.57 %
Jan 1, 2021
10.03 %
Jan 1, 2022
8.37 %
Jan 1, 2023
-105.04 %
Jan 1, 2024
6.32 %
Jan 1, 2025 (e)
47.60 %
Price targets and forecasts for Mercator Medical are not yet available.

Mercator Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/15/2020-PLN-205.74 MPLN-2020 Q1
3/25/2019-PLN-114.69 MPLN-2018 Q4

Mercator Medical shareholder structure

% Name
63.03902%
Zyznowski (Wieslaw)
Zyznowski (Wieslaw)
0.00155%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

Mercator Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
28.6%
Float Shares
-
Shares Outstanding
-

Mercator Medical Executives and Management Board

11 members · avg. age 51 · 27 % women

MZ

Ms. Monika Zyznowska (33)

President of the Management Board

36,000.00 PLN

WZ

Dr. Wieslaw Zyznowski (54)

Member of the Supervisory Board · since 1996

480,000.00 PLN
UZ

Ms. Urszula Zyznowska (48)

Chairman of the Supervisory Board · since 2004

45,400.00 PLN
PS

Mr. Piotr Solorz (48)

Vice Chairman of the Supervisory Board · since 2011

23,400.00 PLN
JK

Mr. Jaroslaw Karasinski (53)

Independent Member of the Supervisory Board

23,400.00 PLN
MS

Dr. Marian Slowiaczek (69)

Independent Member of the Supervisory Board

23,400.00 PLN
MP

Mr. Mariusz Popek

Finance Director, Member of the Management Board

–

Frequently asked questions about Mercator Medical

Mercator Medical SA is a leading healthcare company specializing in the production and distribution of high-quality disposable medical supplies. Its business model revolves around manufacturing and delivering a diverse range of medical gloves, including latex, nitrile, and vinyl gloves, to customers worldwide. With a commitment to quality and innovation, Mercator Medical SA ensures the provision of reliable and safe products to meet the evolving needs of healthcare professionals. By focusing on the production of medical gloves, the company plays a crucial role in promoting proper hygiene and infection control, thereby contributing to improved patient care and safety globally.

Mercator Medical SA is primarily active in the healthcare industry. It specializes in the production and distribution of high-quality medical gloves and other personal protective equipment (PPE). With its extensive range of products, Mercator Medical SA caters to various sectors within the healthcare industry, including hospitals, clinics, laboratories, and the pharmaceutical sector. The company's dedication to providing superior quality products has made it a trusted name in the medical industry. Mercator Medical SA's commitment to the healthcare sector has helped it build a strong reputation and gain recognition as a leading player in the industry.

The main competitors of Mercator Medical SA in the market include other key players in the medical supplies industry such as Ansell Limited, Cardinal Health Inc., and Medline Industries Inc. These companies compete with Mercator Medical SA by offering a range of medical products and services. However, Mercator Medical SA has distinguished itself through its wide product portfolio, global distribution network, and emphasis on quality and innovation. Mercator Medical SA continues to outperform its competitors by consistently delivering high-quality medical supplies and catering to the diverse needs of healthcare professionals worldwide.

Mercator Medical SA is a leading company in the medical and disposable glove industry. Founded in 1996, the company has rapidly grown into a globally recognized brand. Based in Poland, Mercator Medical SA manufactures and distributes a wide range of high-quality medical gloves, including latex, nitrile, and vinyl gloves, catering to healthcare professionals and various industries. With a commitment to innovation and strict adherence to international standards, Mercator Medical SA has established a reputation for delivering reliable and safe products. The company's strong presence in the market, coupled with its dedication to customer satisfaction, has contributed to its success and growth over the years.

Mercator Medical SA has achieved several significant milestones in its history. The company has successfully expanded its presence in the global market, becoming a leading manufacturer and distributor of medical gloves. It has built a strong reputation for delivering high-quality products that meet international standards and regulations. Mercator Medical SA has also experienced substantial financial growth, with increasing revenue and profitability over the years. The company's dedication to innovation and research has resulted in the development of advanced glove technologies, ensuring the safety and comfort of healthcare professionals worldwide. Mercator Medical SA continues to strive for excellence, making it a trusted name in the medical industry.

Mercator Medical SA is primarily present in various countries and regions across the globe. The company has established a strong presence in Poland, where it is headquartered. Additionally, Mercator Medical has expanded its operations to numerous countries and regions, including Europe, Asia, North America, and Latin America. With a commitment to providing high-quality medical products and services, Mercator Medical has successfully gained market share in key healthcare markets worldwide. As a reliable and trusted supplier, the company continues to expand its reach to meet the growing demand for medical supplies and contribute to improving healthcare outcomes on a global scale.

Mercator Medical SA represents strong values and a clear corporate philosophy. The company's core values include professionalism, reliability, and exceptional quality. With a commitment to meeting the needs of the healthcare industry, Mercator Medical SA aims to provide innovative and reliable medical products. The company believes in delivering high-quality goods that enhance patient care and improve overall medical outcomes. With a focus on continuous improvement and a customer-centric approach, Mercator Medical SA strives to build long-term partnerships based on trust and exceptional service.

Converted at the current exchange rate, the Mercator Medical share trades at 12.39 EUR (53.30 PLN).

The Mercator Medical share (MRC.WA) is listed on 5 stock exchanges, including: Frankfurt (MM2.F), München (MM2.MU), London (0QJM.L).

Mercator Medical SA is a Polish company specializing in the production and distribution of medical products in Europe, Asia, and North America. The company operates in three business areas: gloves, medical devices, and real estate.

The revenue cannot currently be calculated for Mercator Medical.

The profit cannot currently be calculated for Mercator Medical.

The P/E ratio cannot be calculated for Mercator Medical at the moment.

The P/S cannot be calculated for Mercator Medical currently.

The Eulerpool Quality Score for Mercator Medical is 3/10.

The ISIN of Mercator Medical is PLMRCTR00015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Mercator Medical is A1XCKG. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Mercator Medical is MRC.WA. The ticker symbol is used to trade Mercator Medical shares on the stock exchange.

The current dividend yield of Mercator Medical is 4.69 %.

Mercator Medical pays a dividend, distributed in the months of , , , .

Mercator Medical paid dividends every year for the past 1 years.

Mercator Medical is assigned to the 'Health' sector.

To receive the latest dividend of Mercator Medical from amounting to 1.61 PLN, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Mercator Medical distributed 2.5 PLN as dividends.

The dividends of Mercator Medical are distributed in PLN.

All fundamentals and in-depth analysis of Mercator Medical

Our stock analysis for Mercator Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mercator Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Mercator Medical Stock
Mercator Medical Revenue→
Mercator Medical Stock
Mercator Medical Net Income→
Mercator Medical Stock
Mercator Medical P/E→
Mercator Medical Stock
Mercator Medical P/S→
Mercator Medical Stock
Mercator Medical EBIT→
Mercator Medical Stock
Mercator Medical Dividend→
Mercator Medical Stock
Mercator Medical Directors Dealings→
Mercator Medical Stock
Mercator Medical Stocks→
Mercator Medical Stock
Mercator Medical Market capitalization→
Mercator Medical Stock
Mercator Medical Debt→
Mercator Medical Stock
Mercator Medical Liabilities→
Mercator Medical Stock
Mercator Medical Equity→
Mercator Medical Stock
Mercator Medical AAQS→
Mercator Medical Stock
Mercator Medical Employees→
Mercator Medical Stock
Mercator Medical ROE→
Mercator Medical Stock
Mercator Medical ROA→
Mercator Medical Stock
Mercator Medical ROCE→
Mercator Medical Stock
Mercator Medical News→
Mercator Medical Stock
Mercator Medical Analyst Price Targets→

Health Stocks

Merchavia Holdings and InvestmentsMera PharmaceuticalsMerck & CoMenticeMerck KGaAMental Health Technologies CoMerck Tbk PTMenicon CoMerdury BiopharmaceuticalMendus AB (publ)Mereo BioPharma GroupMemphis Pharmaceuticals and Chemical Industries SAEAll Stocks A–Z →